Join Penn State Hershey Cancer Institute for the eighth annual melanoma mini-symposium on June 8 in Lecture Room D of the main hospital. The event, focused on the importance of clinical trials for the treatment of melanoma, begins at noon and is scheduled to run until 4:30 p.m.
Program schedule:
| Noon |
Welcome and introduction Gavin P. Robertson, associate professor, Departments of Pharmacology, Pathology, Dermatology, and Surgery |
| 12:15 p.m. |
Melanoma patient’s perspective Alyson Pospisil, melanoma patient advocate |
| 12:30 p.m. |
Melanoma Therapeutics Program update Gavin Robertson |
| 1:00 p.m. |
What a patient needs to know about melanoma Daniel J. Geltrude, co-founder, Mike Geltrude Foundation |
| 1:30 p.m. |
Multidisciplinary skin oncology clinic Rogerio I. Neves, associate professor, Departments of Surgery, Dermatology, and Pharmacology |
| 2:00 p.m. | BREAK |
| 2:15 p.m. |
Advanced melanoma: Are we making progress in treatment? Rene Gonzalez, professor, Medicine/Medical Oncology, University of Colorado, Denver |
| 3:15 p.m. |
New and effective treatments for metastatic melanoma Paul Chapman, attending physician, Melanoma/Sarcoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center |
| 4:15 p.m. |
Closing Remarks Tom Loughran Jr., director, Penn State Hershey Cancer Institute |
For more information, please contact Anton Mulder at (717) 531-0003 ext. 285928.
Share this story
